Goodwill and other intangible assets

12 Months Ended

Jan. 30, 2015

Goodwill and other intangible assets

2. Goodwill and other intangible assets

As of January 30, 2015 and January 31, 2014, the balances of the Company's intangible assets were as follows:

		As of January 30, 2015
(In thousands)	Remaining Life	Amount		Accumulated Amortization		Net
Goodwill	Indefinite	$	4,338,589	$	—	$	4,338,589


Other intangible assets:
Leasehold interests	1 to 8 years	$	18,218	$	16,048	$	2,170
Trade names and trademarks	Indefinite		1,199,700		—		1,199,700

		$	1,217,918	$	16,048	$	1,201,870

		As of January 31, 2014
(In thousands)	Remaining Life	Amount		Accumulated Amortization		Net
Goodwill	Indefinite	$	4,338,589	$	—	$	4,338,589


Other intangible assets:
Leasehold interests	1 to 9 years	$	64,644	$	56,699	$	7,945
Trade names and trademarks	Indefinite		1,199,700		—		1,199,700

		$	1,264,344	$	56,699	$	1,207,645

The Company recorded amortization expense related to amortizable intangible assets for 2014, 2013 and 2012 of $5.8 million, $11.9 million and $16.9 million, respectively, all of which is included in rent expense. Expected future cash flows associated with the Company's intangible assets are not expected to be materially affected by the Company's intent or ability to renew or extend the arrangements. The Company's goodwill balance is not expected to be deductible for tax purposes.

For intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years is as follows: 2015—$0.9 million, 2016—$0.3 million, 2017—$0.2 million, 2018—$0.2 million and 2019—$0.2 million.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details